Wentworth Capital
Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Real Estate, Private Equity, Private Credit, Life Sciences
Stage Focus
Early Stage, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
Australia, New Zealand
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Consumer Goods
- Real Estate
- Infrastructure
- Telecommunications
- Media
- Retail
- Education
- Agriculture
- Transportation
- Life Sciences
- Manufacturing
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2019
Wentworth Capital is a Sydney-based private investment firm specializing in real estate and private equity investments across Australia and New Zealand. The firm focuses on identifying and acquiring real estate opportunities, emphasizing tailored investment strategies to unlock value. Their portfolio includes assets in sectors such as life sciences, technology, healthcare, infrastructure, and financial services.
In December 2025, Wentworth Capital launched Wentworth Private Credit (WPC), a private credit platform providing loans to property owners and developers in underserved market segments. This expansion marks a diversification from traditional real estate equity investments into debt financing for property assets. The platform is led by Issa Chehab, who previously led Blackstone's real estate credit business in Australia for a decade.
Wentworth Capital's investment approach is characterized by a strategic focus on high-quality assets and a commitment to value creation. The firm has a track record of successful investments, including the acquisition of a $200 million life sciences asset in North Ryde, Sydney, in July 2025. This acquisition expanded their Area53 life sciences platform, backed by a joint venture with BlackRock Real Estate. The firm's diversified portfolio and strategic initiatives underscore its position as a significant player in the Australian and New Zealand investment landscape.
Requirements
- Focus on real estate and private equity sectors
- Preference for assets in Australia and New Zealand
- Interest in life sciences, technology, healthcare, infrastructure, and financial services industries
- Opportunities in early-stage to late-stage investments, including pre-IPO, buyout, turnaround, and distressed situations
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Area53 Life Sciences Platform
- Wentworth Private Credit Platform
- CSIRO Headquarters at North Ryde
- 17 O’Riordan Street, Alexandria
- 37 Epping Road, Macquarie Park
- 100-130 Harris Street, Pyrmont
Mentioned In
-
$19.95
-
$99.00
-
$39.95
Claim this Investor
Are you an official representative of Wentworth Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim